{"cdcTestId":"2018-0008","testcaseName":"Zoster: Dose #1 of RZV administered 4 weeks after previous dose of ZVL","vaccineGroup":"ZOSTER","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on minimum interval ","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"1972-09-21T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"ZOSTAVAX","cvx":"121","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-12-14T00:00:00","pastDueDate":"2023-06-15T00:00:00"},"doses":[{"dateAdministered":"2022-09-21T00:00:00","vaccineName":"ZOSTAVAX","cvx":"121","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"zoster recombinant","cvx":"187","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2018-03-28T20:00:00","dateUpdated":"2022-09-27T08:46:01.206","generalDescription":"This test case describes when a patient is administered the first dose of RZV (Shingrix) at 4 weeks after a previous dose of ZVL (Zostavax), that the dose is considered valid. Per current guidance, RZV is recommended to be spaced 8 weeks after ZVL, but it does not need to be repeated if administered at any point prior to that 8 weeks up to and including the same day.","changedInVersion":"4.27","reasonForChange":"v 4.27 Updated Forecast minimum interval from 8 weeks to 4 weeks, to align with ACIP recommendations."}